Anagliptin Completed Phase 4 Trials for Diabetes Mellitus / Dipeptidyl-Peptidase 4 Inhibitors / Glycosylated Hemoglobin / Coronary Heart Disease (CHD) / Cholesterol, LDL Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02330406Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial